Lenalidomide - NDC Database (Page 3)

78 records found

Page:

60219-1718 Feb 12, 2025
Lenalidomide 20 mg Oral Capsule by Amneal Pharmaceuticals Ny LLC

60219-1719 Feb 12, 2025
Lenalidomide 25 mg Oral Capsule by Amneal Pharmaceuticals Ny LLC

60505-4532 Mar 09, 2023
Lenalidomide 2.5 mg Oral Capsule by Apotex Corp.

60505-4533 Sep 06, 2022
Lenalidomide 5 mg Oral Capsule by Apotex Corp.

60505-4534 Sep 06, 2022
Lenalidomide 10 mg Oral Capsule by Apotex Corp.

60505-4535 Sep 06, 2022
Lenalidomide 15 mg Oral Capsule by Apotex Corp.

60505-4536 Mar 09, 2023
Lenalidomide 20 mg Oral Capsule by Apotex Corp.

60505-4537 Sep 06, 2022
Lenalidomide 25 mg Oral Capsule by Apotex Corp.

63304-041 Mar 12, 2023
Lenalidomide 2.5 mg Oral Capsule by Sun Pharmaceutical Industries, Inc.

63304-042 Mar 04, 2023
Lenalidomide 5 mg Oral Capsule by Sun Pharmaceutical Industries, Inc.

63304-043 Mar 04, 2023
Lenalidomide 10 mg Oral Capsule by Sun Pharmaceutical Industries, Inc.

63304-044 Mar 04, 2023
Lenalidomide 15 mg Oral Capsule by Sun Pharmaceutical Industries, Inc.

63304-045 Mar 12, 2023
Lenalidomide 20 mg Oral Capsule by Sun Pharmaceutical Industries, Inc.

63304-046 Mar 04, 2023
Lenalidomide 25 mg Oral Capsule by Sun Pharmaceutical Industries, Inc.

69097-381 Sep 06, 2022
Lenalidomide 5 mg Oral Capsule by Cipla USA Inc.

69097-382 Sep 06, 2022
Lenalidomide 10 mg Oral Capsule by Cipla USA Inc.

69097-383 Sep 06, 2022
Lenalidomide 15 mg Oral Capsule by Cipla USA Inc.

69097-384 Mar 07, 2023
Lenalidomide 20 mg Oral Capsule by Cipla USA Inc.

69097-385 Sep 06, 2022
Lenalidomide 25 mg Oral Capsule by Cipla USA Inc.

69097-604 Mar 09, 2023
Lenalidomide 2.5 mg Oral Capsule by Cipla USA Inc.

Page:

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.